Article
Combined epigenetic/genetic study identified an ALS age of onset modifier.
Acta neuropathologica communications - 23 Apr 2021
Zhang Ming, Xi Zhengrui, Saez-Atienzar Sara, Chia Ruth, Moreno Danielle, Sato Christine, Montazer Haghighi Mahdi, Traynor Bryan J, Zinman Lorne, Rogaeva Ekaterina
Abstract excerpt
Age at onset of amyotrophic lateral sclerosis (ALS) is highly variable (eg, 27-74 years in carriers of the G4C2-expansion in C9orf72). It might be influenced by environmental and genetic factors via the modulation of DNA methylation (DNAm) at CpG-sites. Hence, we combined an epigenetic and genetic approach to test the hypothesis that some common single nucleotide polymorphisms (SNPs) at CpG-sites (CpG-SNPs) could...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
